GlassScriptPhysician profile
Robert A Gatlin
NPI 1508841800
$1,237.93
in general payments reported to CMS, 2019-2025
21 companies · $88.13 in 2025
The $88.13 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $248 · 2020: $259 · 2021: $242 · 2022: $160 · 2023: $106 · 2024: $135 · 2025: $88.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.06 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.23 | 2019-2022 | |
| Myovant Sciences INC. | $142.92 | 2021-2022 | |
| Astellas Pharma US INC | $107.17 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $96.85 | 2020-2025 | Aptima, Thinprep 2000 Processor |
| Amag Pharmaceuticals, INC. | $83.26 | 2019 | |
| Vertical Pharmaceuticals, LLC | $74.89 | 2019-2020 | |
| Avion Pharmaceuticals | $74.77 | 2019-2021 | |
| Therapeuticsmd, INC. | $73.87 | 2020-2021 | |
| Lupin INC. | $59.46 | 2020 | |
| Organon LLC | $54.83 | 2022-2023 | Nexplanon |
| Allergan, INC. | $47.36 | 2019 | |
| Mayne Pharma Commercial LLC | $41.14 | 2023-2025 | |
| Mylan Pharmaceuticals INC. | $21.13 | 2021 | |
| Agile Therapeutics, INC. | $20.31 | 2023 | Twirla |
| Sage Therapeutics, LLC | $19.61 | 2025 | Zurzuvae |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.46 | 2020 | |
| Millicent US INC | $16.46 | 2025 | Femlyv |
| Exeltis, USA INC. | $14.05 | 2020 | |
| Minerva Surgical, INC | $12.25 | 2019 | |
| Merck Sharp & Dohme LLC | $11.90 | 2019 | |
| Daiichi Sankyo INC. | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gatlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.